Advertisement

Sleep

Make CHEST Physician® a trusted source
  • FDA approval of oveporexton for narcolepsy allows clinicians to treat more than symptoms

    FDA approval of oveporexton for narcolepsy allows clinicians to treat more than symptoms

    When the US Food and Drug Administration approved the drug in August, oveporexton became the first agent to target the loss of orexin signaling that causes narcolepsy type 1.


  • Sleep in the ICU: Why closed eyes do not mean rest

    Sleep in the ICU: Why closed eyes do not mean rest

    Unconsciousness is not synonymous with sleep. Available evidence increasingly supports treating sleep as an essential component of ICU care rather than a secondary comfort measure.


  • The evaluation and management of OSA in medically hospitalized patients

    The evaluation and management of OSA in medically hospitalized patients

    These recommendations will hopefully prompt institutions to develop protocols for screening, diagnosing, and potentially offering PAP therapy to this patient population.



  • Study evaluates sleep efficiency change in patients with pediatric OSA following adenotonsillectomy

    Study evaluates sleep efficiency change in patients with pediatric OSA following adenotonsillectomy

    Pediatric pulmonologist Anne C. Coates, MD, said it may take longer to see a benefit from surgery in some populations, especially when nonrespiratory factors may be affecting sleep efficiency.


  • Hypoxic burden from sleep apnea may predict peri-operative outcomes better than AHI

    Hypoxic burden from sleep apnea may predict peri-operative outcomes better than AHI

    Recent results show that sleep apnea-specific hypoxic burden could help inform clinicians whether a patient can safely receive standard postoperative monitoring, said Andrey Zinchuk, MD, MHS.


  • Large, longitudinal study adds to evidence that links OSA to mental health disorder

    Large, longitudinal study adds to evidence that links OSA to mental health disorder

    Colin Huntley, MD, said the data help to confirm what many have seen in the clinic and suggest that patients may see mental health improvements if their sleep apnea is better managed.


  • Study links nocturnal GERD, undiagnosed OSA to worse outcomes in IPF

    Study links nocturnal GERD, undiagnosed OSA to worse outcomes in IPF

    Researchers said the findings support evaluation of sleep‑related comorbidities to identify potentially modifiable contributors to symptoms and physiologic impairment.


  • Intranasal saline improves symptoms in children with sleep-disordered breathing

    Intranasal saline improves symptoms in children with sleep-disordered breathing

    The results of the MIST+ trial support the conclusion that saline is as effective as corticosteroid in managing symptoms of OSDB, said lead author Gillian Nixon, MD.



  • A ‘central’ issue in sleep medicine

    A ‘central’ issue in sleep medicine

    An AASM task force recently published guidelines on central sleep apnea management, which includes recommendations on whether adaptive servo-ventilation is a safe option in these patients.


  • AASM issues first guideline for inpatient management of OSA

    AASM issues first guideline for inpatient management of OSA

    Sleep specialist Dennis H. Auckley, MD, FCCP, said he hopes the recommendations move the field into the inpatient setting and help to identify those with undiagnosed sleep apnea.